Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Aclaris Therapeutics
Biotech
BioMarin CEO replaces commercial chief—Chutes & Ladders
BioMarin CEO replaces commercial chief. Former FDA commissioner Gottlieb joins Comanche board. NextPoint taps former Moderna cancer scientist as CSO.
Max Bayer
,
Gabrielle Masson
Jan 19, 2024 8:30am
Allakos drops lead asset after midphase flops, halves headcount
Jan 16, 2024 9:26am
Aclaris claims ph. 2 win for JAK inhibitor but investors spooked
Jan 10, 2024 8:35am
Aclaris lays off 46%, resurrects zunsemetinib for cancer
Dec 20, 2023 6:09am
Aclaris abandons one MK2 inhibitor over latest phase 2 fail
Nov 13, 2023 8:22am
Aclaris stock sinks after phase 2a skin trial flop
Mar 6, 2023 11:29am
